Opus Genetics (IRD) Gains from Investment Securities (2011 - 2025)
Opus Genetics (IRD) reported Gains from Investment Securities of $100000.0 for Q3 2025, down 83.11% year-over-year from $592222.0 in Q3 2024, and down 99.55% on a QoQ basis from $22.2 million in Q2 2025.
Opus Genetics (IRD) has 15 years of Gains from Investment Securities data on file, last reported at $100000.0 in Q3 2025.
- Quarterly Gains from Investment Securities fell 83.11% year-over-year to $100000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $100000.0 (up 284.62% YoY) and the FY2025 annual result came in at $22.2 million, up 1526.23% from the prior year.
- Gains from Investment Securities fell to $100000.0 in Q3 2025 per IRD's latest filing, from $22.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $22.2 million in Q2 2025 and bottomed at $26000.0 in Q4 2023.
- The 5-year median for Gains from Investment Securities is $259086.0 (2024), against an average of $2.0 million.
- Peak annual rise in Gains from Investment Securities reached 8479.82% in 2025, while the deepest fall reached 83.11% in 2025.
- Tracing IRD's Gains from Investment Securities over 5 years: stood at $128000.0 in 2021, then soared by 30.47% to $167000.0 in 2022, then sank by 84.43% to $26000.0 in 2023, then surged by 2177.78% to $592222.0 in 2024, then plunged by 83.11% to $100000.0 in 2025.
- Per Business Quant, the three latest IRD Gains from Investment Securities figures stand at $100000.0 (Q3 2025), $22.2 million (Q2 2025), and $592222.0 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 22.23 Mn |
| Jun 30, 2025 | 22.23 Mn |
| Sep 30, 2024 | 592,222.00 |
| Sep 30, 2024 | 592,222.00 |
| Jun 30, 2024 | 259,086.00 |
| Jun 30, 2024 | 259,086.00 |
| Mar 31, 2024 | 762,080.00 |
| Mar 31, 2024 | 762,080.00 |
| Dec 31, 2023 | 26,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Sep 30, 2023 | 793,578.00 |
| Sep 30, 2023 | 793,578.00 |
| Jun 30, 2023 | 124,880.00 |
| Jun 30, 2023 | 124,880.00 |
| Mar 31, 2023 | 291,584.00 |
| Mar 31, 2023 | 291,584.00 |
| Sep 30, 2022 | 167,000.00 |
| Sep 30, 2022 | 167,000.00 |
| Sep 30, 2021 | 128,000.00 |
| Sep 30, 2021 | 128,000.00 |
| Jun 30, 2021 | 259,800.00 |
| Jun 30, 2021 | 259,800.00 |
| Mar 31, 2021 | 41,800.00 |
| Mar 31, 2021 | 41,800.00 |
| Jun 30, 2020 | 168,702.00 |
| Jun 30, 2020 | 168,702.00 |
| Mar 31, 2020 | 123,000.00 |
| Mar 31, 2020 | 123,000.00 |
| Dec 31, 2019 | 9,594.00 |
| Dec 31, 2019 | 9,594.00 |
| Sep 30, 2019 | -242,860.00 |
| Sep 30, 2019 | -242,860.00 |
| Jun 30, 2019 | 18,820.00 |
| Jun 30, 2019 | 18,820.00 |
| Mar 31, 2019 | -9,594.00 |
| Mar 31, 2019 | -9,594.00 |
| Dec 31, 2018 | -1.79 Mn |
| Dec 31, 2018 | -1.79 Mn |
| Sep 30, 2018 | 2.29 Mn |
| Sep 30, 2018 | 2.29 Mn |
| Jun 30, 2018 | -1.10 Mn |
| Jun 30, 2018 | -1.10 Mn |
| Mar 31, 2018 | 2.52 Mn |
| Mar 31, 2018 | 2.52 Mn |
| Dec 31, 2017 | 7.50 Mn |
| Dec 31, 2017 | 7.50 Mn |
| Sep 30, 2017 | 483,260.00 |
| Sep 30, 2017 | 483,260.00 |
| Jun 30, 2017 | 97,872.00 |
| Jun 30, 2017 | 97,872.00 |
| Mar 31, 2017 | 338,260.00 |
| Mar 31, 2017 | 338,260.00 |
| Jun 30, 2016 | 448,707.00 |
| Jun 30, 2016 | 448,707.00 |
| Sep 30, 2015 | 4.20 Mn |
| Sep 30, 2015 | 4.20 Mn |
| Jun 30, 2015 | 3.73 Mn |
| Jun 30, 2015 | 3.73 Mn |
| Mar 31, 2015 | 98,051.00 |
| Mar 31, 2015 | 98,051.00 |
| Sep 30, 2014 | 11.27 Mn |
| Sep 30, 2014 | 11.27 Mn |
| Jun 30, 2014 | 48,125.00 |
| Jun 30, 2014 | 48,125.00 |
| Mar 31, 2014 | 975,999.00 |
| Mar 31, 2014 | 975,999.00 |
| Sep 30, 2013 | 91,300.00 |
| Sep 30, 2013 | 91,300.00 |
| Mar 31, 2013 | 1.75 Mn |
| Mar 31, 2013 | 1.75 Mn |
| Sep 30, 2012 | 150,000.00 |
| Sep 30, 2012 | 150,000.00 |
| Jun 30, 2012 | 50,000.00 |
| Jun 30, 2012 | 50,000.00 |
| Mar 31, 2012 | 75,000.00 |
| Mar 31, 2012 | 75,000.00 |
| Dec 31, 2011 | -107,410.00 |
| Dec 31, 2011 | -107,410.00 |
| Sep 30, 2011 | 192,000.00 |
| Sep 30, 2011 | 192,000.00 |
| Jun 30, 2011 | -3,960.00 |
| Jun 30, 2011 | -3,960.00 |